Therefore, it is conceivable that IL-1β secreted from immune and melanoma cells in the tumor inflammatory microenvironment contributes to progression of cancer, including angiogenesis, invasion, and metastasis, via COX-2 expression and subsequent prostaglandin E2 production and release [45–47]. The gene discussed is IL1B; the disease is neoplasm.